Related Experiment Video
Updated: Feb 22, 2026
06:33
Production of Human CRISPR-Engineered CAR-T Cells
Published on: March 15, 2021
14.7K
Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic
Dianne Nicol1, Lisa Eckstein2, Michael Morrison3
1Centre for Law and Genetics, Faculty of Law, University of Tasmania, Hobart, 7001, Australia. Dianne.Nicol@utas.edu.au.
Genome Medicine
|September 27, 2017
Summary
Genome editing with CRISPR technology shows promise for treating genetic diseases. However, significant challenges remain for the clinical application of CRISPR-mediated somatic cell therapy.
Area of Science:
- Biotechnology
- Genetics
- Medical Ethics
Background:
- Clustered regularly interspersed short palindromic repeats (CRISPR) technology offers novel therapeutic potential for genetic disorders.
- CRISPR-mediated somatic cell therapy aims to treat diseases at the genetic level.
Purpose of the Study:
- To identify key challenges in the clinical translation of CRISPR-mediated somatic cell therapy.
- To address hurdles faced by clinicians, regulators, and ethics committees.
Main Methods:
- Literature review and expert consultation on CRISPR clinical translation.
- Analysis of regulatory and ethical frameworks for gene therapy.
Main Results:
- Identified significant challenges in clinical translation of CRISPR therapy.
- Highlighted the need for robust regulatory and ethical guidelines.
Conclusions:
- Clinical translation of CRISPR-mediated somatic cell therapy requires addressing multifaceted challenges.
- Collaboration among clinicians, regulators, and ethicists is crucial for safe and effective implementation.
Related Concept Videos
01:06Induced Pluripotent Stem Cells
5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.7K
01:59CRISPR
58.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.2K
01:29Somatic to iPS Cell Reprogramming
2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
00:49What is Genetic Engineering?
80.6K
Overview
80.6K
01:24Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
01:28CRISPR/Cas9 Genome Editing
2.1K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.1K